Actively Recruiting
A Long-term Follow-up of the HIV-NAT Cohort
Led by The HIV Netherlands Australia Thailand Research Collaboration · Updated on 2025-03-17
10000
Participants Needed
1
Research Sites
1465 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
With HIV/AIDS increasingly considered a chronic disease, 24-, or 48-week data from antiretroviral studies are no longer sufficient. Only with long-term follow-up and outcome data will shed some much-needed light on the answers of questions that have stumped us for several years. Data from a large observational cohort of patients treated with combination antiretroviral therapy will provide further insights into the long-term safety and durability of various antiretroviral therapeutic approached, the efficacy of HIV viral load and CD4 cell counts as predictors of disease progression and mortality, and the importance of adherence.
CONDITIONS
Official Title
A Long-term Follow-up of the HIV-NAT Cohort
Who Can Participate
Eligibility Criteria
You may qualify if you...
- HIV infected patients (children and adults) who previously participated in HIV-NAT studies
- HIV infected patients (children and adults) who currently participate in HIV-NAT trials
- Able to provide written consent
You will not qualify if you...
- Unable to provide written consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
HIV-NAT, Thai Red Cross AIDS Research Center
Bangkok, Thailand, 10330
Actively Recruiting
Research Team
A
Anchalee Avihingsanon, MD, PhD
CONTACT
S
Stephen Kerr, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here